ARMISTICE CAPITAL, LLC - 31 Dec 2025 SCHEDULE 13G Report for AGIOS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (AGIO)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: AGIOS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share
Symbol: AGIO
Shares outstanding: 58,272,553 shares
Disclosed Ownership: 3,036,000 shares
Ownership: 5.2%
Form type: SCHEDULE 13G
Filing time: 17 Feb 2026, 21:54:30 UTC
Date of event: 31 Dec 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	5.2%	3,036,000	0	3,036,000	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	5.2%	3,036,000	0	3,036,000	/s/ Steven Boyd	Steven Boyd